位置:首页 > 蛋白库 > ZN207_XENLA
ZN207_XENLA
ID   ZN207_XENLA             Reviewed;         452 AA.
AC   Q7ZXV8;
DT   16-APR-2014, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   03-AUG-2022, entry version 70.
DE   RecName: Full=BUB3-interacting and GLEBS motif-containing protein ZNF207 {ECO:0000250|UniProtKB:O43670};
DE            Short=BuGZ {ECO:0000250|UniProtKB:O43670};
DE            Short=xBuGZ {ECO:0000303|PubMed:26388440};
DE   AltName: Full=Zinc finger protein 207 {ECO:0000250|UniProtKB:O43670};
GN   Name=znf207 {ECO:0000250|UniProtKB:O43670};
GN   Synonyms=bugz {ECO:0000250|UniProtKB:O43670};
OS   Xenopus laevis (African clawed frog).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Amphibia;
OC   Batrachia; Anura; Pipoidea; Pipidae; Xenopodinae; Xenopus; Xenopus.
OX   NCBI_TaxID=8355;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Embryo;
RG   NIH - Xenopus Gene Collection (XGC) project;
RL   Submitted (JAN-2003) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   INTERACTION WITH BUB3.
RX   PubMed=24462186; DOI=10.1016/j.devcel.2013.12.013;
RA   Jiang H., He X., Wang S., Jia J., Wan Y., Wang Y., Zeng R., Yates J. III,
RA   Zhu X., Zheng Y.;
RT   "A microtubule-associated zinc finger protein, BuGZ, regulates mitotic
RT   chromosome alignment by ensuring Bub3 stability and kinetochore
RT   targeting.";
RL   Dev. Cell 28:268-281(2014).
RN   [3]
RP   FUNCTION, SUBCELLULAR LOCATION, DOMAIN, AND MUTAGENESIS OF TYR-117;
RP   PHE-129; PHE-138; PHE-256; PHE-274; PHE-292; TYR-295; TYR-352; TYR-402;
RP   TYR-412; PHE-420; PHE-430 AND TYR-452.
RX   PubMed=26388440; DOI=10.1016/j.cell.2015.08.010;
RA   Jiang H., Wang S., Huang Y., He X., Cui H., Zhu X., Zheng Y.;
RT   "Phase transition of spindle-associated protein regulate spindle apparatus
RT   assembly.";
RL   Cell 163:108-122(2015).
CC   -!- FUNCTION: Kinetochore- and microtubule-binding protein that plays a key
CC       role in spindle assembly. Znf207/BuGZ is mainly composed of disordered
CC       low-complexity regions and undergoes phase transition or coacervation
CC       to form temperature-dependent liquid droplets. Coacervation promotes
CC       microtubule bundling and concentrates tubulin, promoting microtubule
CC       polymerization and assembly of spindle and spindle matrix by
CC       concentrating its building blocks. {ECO:0000269|PubMed:26388440}.
CC   -!- SUBUNIT: Interacts (via GLEBS region) with bub3.
CC       {ECO:0000269|PubMed:24462186}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:O43670}.
CC       Chromosome, centromere, kinetochore {ECO:0000250|UniProtKB:O43670}.
CC       Cytoplasm, cytoskeleton, spindle {ECO:0000269|PubMed:26388440}.
CC       Note=Localizes primarily to the nucleus in interphase, concentrates at
CC       kinetochores prior to nuclear envelope breakdown and during early
CC       prometaphase, and disappears from kinetochores upon microtubule-
CC       binding. {ECO:0000250|UniProtKB:O43670}.
CC   -!- DOMAIN: The GLEBS region mediates interaction with bub3.
CC       {ECO:0000250|UniProtKB:O43670}.
CC   -!- DOMAIN: Mainly composed of disordered low-complexity regions outside of
CC       the C2H2-type zinc fingers. Coacervation depends on hydrophobic and
CC       aromatic Phe and Tyr in the disordered low-complexity region, that may
CC       promote coacervation by forming intermolecular hydrophobic
CC       interactions. {ECO:0000269|PubMed:26388440}.
CC   -!- DOMAIN: The microtubule-binding region is required for efficient
CC       loading of bub3 onto kinetochores and proper mitosis.
CC       {ECO:0000250|UniProtKB:O43670}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC044099; AAH44099.1; -; mRNA.
DR   RefSeq; NP_001080324.1; NM_001086855.1.
DR   AlphaFoldDB; Q7ZXV8; -.
DR   SMR; Q7ZXV8; -.
DR   DNASU; 380016; -.
DR   GeneID; 380016; -.
DR   KEGG; xla:380016; -.
DR   CTD; 380016; -.
DR   Xenbase; XB-GENE-997707; znf207.S.
DR   OrthoDB; 1453306at2759; -.
DR   Proteomes; UP000186698; Chromosome 9_10S.
DR   Bgee; 380016; Expressed in gastrula and 19 other tissues.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-KW.
DR   GO; GO:0000776; C:kinetochore; ISS:UniProtKB.
DR   GO; GO:0005874; C:microtubule; IEA:UniProtKB-KW.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005819; C:spindle; IEA:UniProtKB-SubCell.
DR   GO; GO:1990047; C:spindle matrix; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008017; F:microtubule binding; IDA:UniProtKB.
DR   GO; GO:0008608; P:attachment of spindle microtubules to kinetochore; ISS:UniProtKB.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0001578; P:microtubule bundle formation; IDA:UniProtKB.
DR   GO; GO:0046785; P:microtubule polymerization; IDA:UniProtKB.
DR   GO; GO:0000070; P:mitotic sister chromatid segregation; ISS:UniProtKB.
DR   GO; GO:0090307; P:mitotic spindle assembly; IDA:UniProtKB.
DR   GO; GO:0007094; P:mitotic spindle assembly checkpoint signaling; ISS:UniProtKB.
DR   GO; GO:0050821; P:protein stabilization; ISS:UniProtKB.
DR   GO; GO:0051983; P:regulation of chromosome segregation; ISS:UniProtKB.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   SMART; SM00355; ZnF_C2H2; 2.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 2.
PE   1: Evidence at protein level;
KW   Cell cycle; Cell division; Centromere; Chromosome; Chromosome partition;
KW   Cytoplasm; Cytoskeleton; Kinetochore; Metal-binding; Microtubule; Mitosis;
KW   Nucleus; Reference proteome; Repeat; Zinc; Zinc-finger.
FT   CHAIN           1..452
FT                   /note="BUB3-interacting and GLEBS motif-containing protein
FT                   ZNF207"
FT                   /id="PRO_0000428734"
FT   ZN_FING         11..34
FT                   /note="C2H2-type 1"
FT   ZN_FING         35..58
FT                   /note="C2H2-type 2"
FT   REGION          1..92
FT                   /note="Microtubule-binding region"
FT                   /evidence="ECO:0000250|UniProtKB:O43670"
FT   REGION          99..131
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          298..330
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          329..361
FT                   /note="GLEBS"
FT                   /evidence="ECO:0000250|UniProtKB:O43670"
FT   COMPBIAS        99..114
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MUTAGEN         117
FT                   /note="Y->S: In xBuGZ13S: Impaired coacervation; when
FT                   associated with S-129; S-138; S-256; S-274; S-292; S-295;
FT                   S-352; S-402; S-412; S-420; S-430 and S-452."
FT                   /evidence="ECO:0000269|PubMed:26388440"
FT   MUTAGEN         129
FT                   /note="F->S: In xBuGZ13S: Impaired coacervation; when
FT                   associated with S-117; S-138; S-256; S-274; S-292; S-295;
FT                   S-352; S-402; S-412; S-420; S-430 and S-452."
FT                   /evidence="ECO:0000269|PubMed:26388440"
FT   MUTAGEN         138
FT                   /note="F->S: In xBuGZ13S: Impaired coacervation; when
FT                   associated with S-117; S-129; S-256; S-274; S-292; S-295;
FT                   S-352; S-402; S-412; S-420; S-430 and S-452."
FT                   /evidence="ECO:0000269|PubMed:26388440"
FT   MUTAGEN         256
FT                   /note="F->S: In xBuGZ13S: Impaired coacervation; when
FT                   associated with S-117; S-129; S-138; S-274; S-292; S-295;
FT                   S-352; S-402; S-412; S-420; S-430 and S-452."
FT                   /evidence="ECO:0000269|PubMed:26388440"
FT   MUTAGEN         274
FT                   /note="F->S: In xBuGZ13S: Impaired coacervation; when
FT                   associated with S-117; S-129; S-138; S-256; S-292; S-295;
FT                   S-352; S-402; S-412; S-420; S-430 and S-452."
FT                   /evidence="ECO:0000269|PubMed:26388440"
FT   MUTAGEN         292
FT                   /note="F->S: In xBuGZ13S: Impaired coacervation; when
FT                   associated with S-117; S-129; S-138; S-256; S-274; S-295;
FT                   S-352; S-402; S-412; S-420; S-430 and S-452."
FT                   /evidence="ECO:0000269|PubMed:26388440"
FT   MUTAGEN         295
FT                   /note="Y->S: In xBuGZ13S: Impaired coacervation; when
FT                   associated with S-117; S-129; S-138; S-256; S-274; S-292;
FT                   S-352; S-402; S-412; S-420; S-430 and S-452."
FT                   /evidence="ECO:0000269|PubMed:26388440"
FT   MUTAGEN         352
FT                   /note="Y->S: In xBuGZ13S: Impaired coacervation; when
FT                   associated with S-117; S-129; S-138; S-256; S-274; S-292;
FT                   S-295; S-402; S-412; S-420; S-430 and S-452."
FT                   /evidence="ECO:0000269|PubMed:26388440"
FT   MUTAGEN         402
FT                   /note="Y->S: In xBuGZ13S: Impaired coacervation; when
FT                   associated with S-117; S-129; S-138; S-256; S-274; S-292;
FT                   S-295; S-352; S-412; S-420; S-430 and S-452."
FT                   /evidence="ECO:0000269|PubMed:26388440"
FT   MUTAGEN         412
FT                   /note="Y->S: In xBuGZ13S: Impaired coacervation; when
FT                   associated with S-117; S-129; S-138; S-256; S-274; S-292;
FT                   S-295; S-352; S-402; S-420; S-430 and S-452."
FT                   /evidence="ECO:0000269|PubMed:26388440"
FT   MUTAGEN         420
FT                   /note="F->S: In xBuGZ13S: Impaired coacervation; when
FT                   associated with S-117; S-129; S-138; S-256; S-274; S-292;
FT                   S-295; S-352; S-402; S-412; S-430 and S-452."
FT                   /evidence="ECO:0000269|PubMed:26388440"
FT   MUTAGEN         430
FT                   /note="F->S: In xBuGZ13S: Impaired coacervation; when
FT                   associated with S-117; S-129; S-138; S-256; S-274; S-292;
FT                   S-295; S-352; S-402; S-412; S-420 and S-452."
FT                   /evidence="ECO:0000269|PubMed:26388440"
FT   MUTAGEN         452
FT                   /note="Y->S: In xBuGZ13S: Impaired coacervation; when
FT                   associated with S-117; S-129; S-138; S-256; S-274; S-292;
FT                   S-295; S-352; S-402; S-412; S-420 and S-430."
FT                   /evidence="ECO:0000269|PubMed:26388440"
SQ   SEQUENCE   452 AA;  48549 MW;  B02A4DA4F7ED6ED1 CRC64;
     MGRKKKKQLK PWCWYCNRDF DDEKILIQHQ KAKHFKCHIC HKKLYTGPGL AIHCMQVHKE
     TIDAVPNAIP GRTDIELEIY GMEGIPEKDM EERRRILEQK TQVDGQKKKT NQDDSDYDDD
     DDTAPSTSFQ QMQTQQAFMP TMGQPGIPGL PGAPGMPPGI TSLMPAVPPL ISGIPHVMAG
     MHPHGMMSMG GMMHPHRPGI PPMMAGLPPG VPPPGLRPGI PPVTQAQPAL SQAVVSRLPV
     PSTSAPALQS VPKPLFPSAG QAQAHISGPV GTDFKPLNNI PATTAEHPKP TFPAYTQSTM
     STTSTTNSTA SKPSTSITSK PATLTTTSAT SKLVHPDEDI SLEEKRAQLP KYQRNLPRPG
     QAPISNMGST AVGPLGAMMA PRPGLPPQQH GMRHPLPPHG QYGAPLQGMA GYHPGTMPPF
     GQGPPMVPPF QGGPPRPLMG IRPPVMSQGG RY
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024